Literature DB >> 16425998

Diagnostic implications of antigen-induced gamma interferon production by blood leukocytes from Mycobacterium bovis-infected reindeer (Rangifer tarandus).

W R Waters1, M V Palmer, R E Slaughter, S L Jones, J E Pitzer, F C Minion.   

Abstract

The only approved method of tuberculosis (TB) surveillance of reindeer within the United States is tuberculin skin testing; however, skin testing has an apparent lack of specificity, since numerous reindeer are classified as reactors, yet Mycobacterium bovis is not isolated from tissues upon necropsy. The objective of this study was to evaluate the ability of an in vitro assay (the Cervigam assay) to detect gamma interferon (IFN-gamma) produced by blood leukocytes in response to mycobacterial antigens from M. bovis-infected reindeer. Thirteen male reindeer approximately 9 months of age were inoculated with 10(5) CFU M. bovis in their tonsillar crypts. Stimulation of whole-blood cultures with a mitogen resulted in significant production of IFN-gamma compared to that by nonstimulated samples. Responses by infected reindeer to M. bovis purified protein derivative (PPD) were as much as 3.5-fold higher than those by noninfected reindeer (n = 4). Despite differences in responses to PPD by the two groups, reindeer within the noninfected group had responses of >0.1 change in optical density (DeltaOD) (a level generally considered positive) to PPD. Mean responses by infected reindeer to a rESAT-6-CFP-10 fusion protein (Mycobacterium tuberculosis complex specific) were as much as 20-fold higher than respective responses by noninfected reindeer at all time points. Additionally, responses by 3/4 noninfected reindeer were <0.1 DeltaOD (considered negative) at each time point. To further evaluate the specificity of the assay, samples were collected from reindeer in a TB-free herd. All reindeer had responses to mitogen; however, only 1 of 38 had a response to PPD, and none of the reindeer responded to rESAT-6-CFP-10. Together, these findings indicate that IFN-gamma-based tests may prove useful for TB surveillance of reindeer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425998      PMCID: PMC1356622          DOI: 10.1128/CVI.13.1.37-44.2006

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  31 in total

1.  ESAT-6 and CFP-10: what is the diagnosis?

Authors:  Nico C Gey van Pittius; Robin M Warren; Paul D van Helden
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Uncommon presentations of tuberculosis: the potential value of a novel diagnostic assay based on the Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10.

Authors:  S M Arend; T H Ottenhoff; P Andersen; J T van Dissel
Journal:  Int J Tuberc Lung Dis       Date:  2001-07       Impact factor: 2.373

3.  Tuberculin skin testing in white-tailed deer (Odocoileus virginianus).

Authors:  M V Palmer; D L Whipple; W R Waters
Journal:  J Vet Diagn Invest       Date:  2001-11       Impact factor: 1.279

4.  Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis.

Authors:  Annemieke Geluk; Krista E van Meijgaarden; Kees L M C Franken; Yanri W Subronto; Brigitte Wieles; Sandra M Arend; Elizabeth P Sampaio; Tjitske de Boer; William R Faber; Ben Naafs; Tom H M Ottenhoff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence.

Authors:  Philip S Renshaw; Parthena Panagiotidou; Adam Whelan; Stephen V Gordon; R Glyn Hewinson; Richard A Williamson; Mark D Carr
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

6.  Immune responses of elk to Mycobacterium bovis bacillus Calmette Guerin vaccination.

Authors:  W R Waters; M V Palmer; S C Olsen; R E Sacco; D L Whipple
Journal:  Vaccine       Date:  2003-03-28       Impact factor: 3.641

7.  Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle.

Authors:  B M Buddle; A R McCarthy; T J Ryan; J M Pollock; H M Vordermeier; R G Hewinson; P Andersen; G W de Lisle
Journal:  Vet Rec       Date:  2003-11-15       Impact factor: 2.695

8.  Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis.

Authors:  A Geluk; K E van Meijgaarden; K L M C Franken; B Wieles; S M Arend; W R Faber; B Naafs; T H M Ottenhoff
Journal:  Scand J Immunol       Date:  2004-01       Impact factor: 3.487

9.  Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii.

Authors:  Sandra M Arend; Krista E van Meijgaarden; Kirsten de Boer; Elisabeth Cerdá de Palou; Dick van Soolingen; Tom H M Ottenhoff; Jaap T van Dissel
Journal:  J Infect Dis       Date:  2002-11-19       Impact factor: 5.226

10.  The gamma-interferon test: its usefulness in a bovine tuberculosis survey in African buffaloes (Syncerus caffer) in the Kruger National Park.

Authors:  D G Grobler; Anita L Michel; Lin-Mari De Klerk; R G Bengis
Journal:  Onderstepoort J Vet Res       Date:  2002-09       Impact factor: 1.792

View more
  1 in total

1.  Development and evaluation of a real-time reverse transcription-PCR assay for quantification of gamma interferon mRNA to diagnose tuberculosis in multiple animal species.

Authors:  Noel P Harrington; Om P Surujballi; W Ray Waters; John F Prescott
Journal:  Clin Vaccine Immunol       Date:  2007-10-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.